Much of the research we publish relates to questions of cause and effect. In an ideal world, we would subject these questions ...

We recently compiled a list of the 10 Worst ADR Stocks To Buy According to Short Sellers. In this article, we are going to ...

The study, published in the Journal of the American Heart Association, revealed a strong connection between individual ...

The median interval from cancer diagnosis to randomization was 11.7 months (4.0-26.4). The ponsegromab 400-mg group had the highest proportion of patients with stage IV disease (86% vs 65-74% in the ...

Limitations of the study include the low sample sizes, and the exploratory, post hoc nature of the study which did not allow for statistical testing, randomization, or a control group. “This work ...

The U.S. Food and Drug Administration (FDA) issued this week three guidance documents related to clinical trials: a draft ...

A recent innovative multicenter study conducted in China has found that tenecteplase, a bioengineered variant of alteplase, ...

Researchers leading the SWOG S1712 clinical trial have found that adding ruxolitinib to standard tyrosine kinase inhibitor ...

New research suggests vitamin D supplements may have both benefits and risks, potentially reducing cancer risk while increasing the chances of heart disease. The findings, published in the Annals of ...